One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2019-131779
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 7 |
Affiliation: University of Bologna, Humanitas University, Hôpital Maisonneuve-Rosemont, Helsinki University Hospital, Cambridge University Hospitals NHS Foundation Trust, University Hospital Münster, Samsung (South Korea), Tel Aviv University, National and Kapodistrian University of Athens, Semmelweis University, University of Lille, Centre Hospitalier Universitaire de Lille, Bayer (United States), LMU KlinikumCopanlisib, a PI3K Inhibitor, Demonstrates a Favorable Long-Term Safety Profile in a Pooled Analysis of Patients with Hematologic Malignancies
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
